Subscribe
The market is overlooking the growth capabilities of this IT company, says STS Global Income & Growth’s James Harries
This company is well-positioned to keep gaining market share, says investment manager Metropolis
Following a tricky second quarter, are market conditions favouring biotechs?
Portfolio Clinic: With sizeable assets, our reader wonders what else needs to be done as he considers an early retirement. Dave Baxter takes a look
A breathless rally has lifted plenty of portfolios
Visma’s listing is excellent news for London, but comes with complications for its private equity owners
What to look out for when picking a portfolio
Some of the sector’s top names are widening the net beyond London
Prioritising returns over yield, and businesses over contracts, this fund’s unique approach is paying offÂ
After a brief interlude over the summer, Saba is renewing its focus on the investment trust sector and is working on a UK ETF
